122 related articles for article (PubMed ID: 2050427)
1. C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.
de Bel C; Gerritsen E; de Maaker G; Moolenaar A; Vossen J
Infection; 1991; 19(2):92-6. PubMed ID: 2050427
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.
Saarinen UM; Strandjord SE; Warkentin PI; Cheung NK; Lazarus HM; Coccia PF
Transplantation; 1987 Oct; 44(4):540-6. PubMed ID: 3313843
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation.
Schwaighofer H; Herold M; Schwarz T; Nordberg J; Ceska M; Prior C; Nachbaur D; Weyrer W; Brankova J; Eibl B
Transplantation; 1994 Aug; 58(4):430-6. PubMed ID: 8073511
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.
Rowe IF; Worsley AM; Donnelly P; Catovsky D; Goldman JM; Galton D; Pepys MB
J Clin Pathol; 1984 Mar; 37(3):263-6. PubMed ID: 6365979
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
6. Serum C-reactive protein levels in the management of infection in acute leukaemia.
Starke ID; de Beer FC; Donnelly JP; Catovsky D; Goldman JM; Galton DA; Pepys MB
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):319-25. PubMed ID: 6584311
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.
Uguccioni M; Meliconi R; Lalli E; Nesci S; Delfini C; Lucarelli G; Gasbarrini G; Facchini A
J Clin Pathol; 1992 Apr; 45(4):348-51. PubMed ID: 1577974
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
Santolaya ME; Cofre J; Beresi V
Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
[TBL] [Abstract][Full Text] [Related]
10. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.
Vettenranta K; Hovi L; Mäkipernaa A; Jalanko H; Saarinen-Pihkala UM
Acta Paediatr; 2002; 91(8):915-9. PubMed ID: 12222715
[TBL] [Abstract][Full Text] [Related]
12. The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation.
Rintala E; Remes K; Salmi TT; Koskinen P; Nikoskelainen J
Infection; 1997; 25(6):335-8. PubMed ID: 9427050
[TBL] [Abstract][Full Text] [Related]
13. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and fever in neutropenic patients.
Arber C; Passweg JR; Fluckiger U; Pless M; Gregor M; Tichelli A; Schifferli JA; Gratwohl A
Scand J Infect Dis; 2000; 32(5):515-20. PubMed ID: 11055657
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
16. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
17. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children after cardiac surgery.
Nahum E; Livni G; Schiller O; Bitan S; Ashkenazi S; Dagan O
J Intensive Care Med; 2012; 27(3):191-6. PubMed ID: 21561990
[TBL] [Abstract][Full Text] [Related]
18. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.
Nevo S; Enger C; Swan V; Wojno KJ; Fuller AK; Altomonte V; Braine HG; Noga SJ; Vogelsang GB
Transplantation; 1999 Mar; 67(5):681-9. PubMed ID: 10096522
[TBL] [Abstract][Full Text] [Related]
19. Plasma neopterin as an adjunct to C-reactive protein in assessment of infection.
Sheldon J; Riches PG; Soni N; Jurges E; Gore M; Dadian G; Hobbs JR
Clin Chem; 1991 Dec; 37(12):2038-42. PubMed ID: 1764778
[TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
